European Investment Bank — 2026 Investments
2 investments dated 2026 · listed companies and verified rows first · show all
BioLamina develops full-length human recombinant laminin proteins and related cell culture substrates for research and clinical applications.
BiotechDeep TechDigital HealthHealthtechMedical DevicesNew MaterialsStockholm, SE
Kristian Tryggvason(Founder and Board Member)inKarl Tryggvason
Co-investorsLauxera Capital Partners
Veloq provides a modular end-to-end technology platform for online same-day grocery, covering fulfillment centres, micro-fulfilment automation, AI-powered last-mile routing, and eCommerce storefronts.
Logistics & Supply ChainRetail TechSaaS
Co-investorsTCF Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.